Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bionano Genomics Inc (BNGO)

Bionano Genomics Inc (BNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 47,584
  • Shares Outstanding, K 54,694
  • Annual Sales, $ 36,120 K
  • Annual Income, $ -232,490 K
  • 60-Month Beta 2.33
  • Price/Sales 1.48
  • Price/Cash Flow N/A
  • Price/Book 0.47
Trade BNGO with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -4.88
  • Most Recent Earnings $-0.96 on 03/05/24
  • Latest Earnings Date 05/14/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 118.27% ( -46.91%)
  • Historical Volatility 55.41%
  • IV Percentile 71%
  • IV Rank 28.30%
  • IV High 310.48% on 01/12/24
  • IV Low 42.41% on 11/13/23
  • Put/Call Vol Ratio 0.46
  • Today's Volume 165
  • Volume Avg (30-Day) 198
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 43,958
  • Open Int (30-Day) 42,923

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -1.20
  • Growth Rate Est. (year over year) +83,350.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8500 +1.18%
on 04/16/24
1.1700 -26.50%
on 03/28/24
-0.1500 (-14.85%)
since 03/15/24
3-Month
0.8500 +1.18%
on 04/16/24
1.4000 -38.57%
on 01/23/24
-0.4300 (-33.33%)
since 01/16/24
52-Week
0.8500 +1.18%
on 04/16/24
9.8000 -91.22%
on 04/17/23
-10.0400 (-92.11%)
since 04/14/23

Most Recent Stories

More News
Bionano Genomics (BNGO) Q4 2023 Earnings Call Transcript

BNGO earnings call for the period ending December 31, 2023.

BNGO : 0.8600 (-1.15%)
Bionano Genomics (BNGO) Q3 2023 Earnings Call Transcript

BNGO earnings call for the period ending September 30, 2023.

BNGO : 0.8600 (-1.15%)
Why Bionano Genomics Stock Tanked Today

A CFO departure shines a light on some of the company's recent struggles.

AIG : 73.81 (+1.04%)
DGX : 127.42 (-0.95%)
BNGO : 0.8600 (-1.15%)
Bionano Genomics (BNGO) Q2 2023 Earnings Call Transcript

BNGO earnings call for the period ending June 30, 2023.

BNGO : 0.8600 (-1.15%)
Bionano Genomics (BNGO) Q1 2023 Earnings Call Transcript

BNGO earnings call for the period ending March 31, 2023.

BNGO : 0.8600 (-1.15%)
Bionano Genomics, Inc. (BNGO) Reports Q1 Loss, Tops Revenue Estimates

Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of -33.33% and 1.72%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

BNGO : 0.8600 (-1.15%)
ADMA : 6.16 (+3.01%)
Better Gene Sequencing Stock: Illumina vs. Bionano Genomics

This is a classic matchup of a grizzled top dog against a scrappy competitor.

ILMN : 117.69 (-2.86%)
BNGO : 0.8600 (-1.15%)
Why Shares of Bionano Genomics Are Up Monday

The life sciences company said it expects another improved quarter of revenue.

BNGO : 0.8600 (-1.15%)
3 Supercharged Growth Stocks With 662% to 741% Upside, According to Wall Street

These fast-paced stocks are on the cutting edge of innovation, and select Wall Street analysts and pundits expect them to skyrocket.

TSLA : 157.11 (-2.71%)
BNGO : 0.8600 (-1.15%)
PLUG : 2.70 (-5.26%)
Buy This Magnificent Growth Stock Before It's Too Late

Bionano is gaining momentum and could soon be approaching escape velocity.

BNGO : 0.8600 (-1.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

BioNano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The Company offers proprietary nanochannel chips, automated imaging instrument, integrated primary and secondary software, and application specific reagents. BioNano Genomics, Inc. is based in San...

See More

Key Turning Points

3rd Resistance Point 0.9900
2nd Resistance Point 0.9600
1st Resistance Point 0.9100
Last Price 0.8600
1st Support Level 0.8300
2nd Support Level 0.8000
3rd Support Level 0.7500

See More

52-Week High 9.8000
Fibonacci 61.8% 6.3811
Fibonacci 50% 5.3250
Fibonacci 38.2% 4.2689
Last Price 0.8600
52-Week Low 0.8500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar